Parataxis will launch a Bitcoin-native treasury platform in South Korea via Bridge Bio, aiming to expand institutional access to BTC despite regulatory barriers.
Korean biotech firm bought by Parataxis for Bitcoin treasury use
Related posts
Ethereum could reach $8.5K if Bitcoin taps $150K, trader says
Ethereum whales scoop sales by traders in ‘disbelief’ of rally: Santiment
Ethereum hits new multiyear high as Tom Lee’s BitMine plans $20B ETH raise
BitMine targets huge $24.5B raise as SharpLink boosts Ether war chest
SEC to focus on ‘clear’ crypto regulations after Ripple case: Atkins
